PNNL

Abstract

Small-conductance (KCa2.2) and intermediate-conductance (KCa3.1) Ca2+-activated K+ 30 channels are gated by a Ca2+ -calmodulin dependent mechanism. NS309 potentiates the activity of both KCa2.2 and KCa3.1, while rimtuzalcap selectively activates KCa2.2. Rimtuzalcap has been used in clinical trials for the treatment of spinocerebellar ataxia and essential tremor. We report cryo electron microscopy structures of KCa2.2 channels bound with NS309 and rimtuzalcap, in addition to KCa3.1 channels with NS309. The different conformations of calmodulin and the cytoplasmic HC helices in the two channels underlie the subtype-selectivity of rimtuzalcap for KCa2.2. Calmodulin’s N-lobes in the KCa2.2 structure are far apart and undergo conformational changes to accommodate either NS309 or rimtuzalcap. Calmodulin’s N-lobes in the KCa3.1 structure are closer to each other and are constrained by the HC helices of KCa3.1, which allows binding of NS309 but not of the bulkier rimtuzalcap. These structures provide a framework for structure41 based drug design targeting KCa2.2 channels.